Severn Health Solutions

St. Agnes Pathology in Baltimore, MD offers personalized and compassionate care through a network of healthcare professionals and specialists, providing a range of services close to home. Their care teams prioritize understanding each individual's health and life to deliver tailored care that meets the unique needs of patients and their families. As part of the Ascension network, St. Agnes Pathology is committed to advocating for a more just and compassionate society, addressing issues of diversity, inclusion, and equity in healthcare. Patients can access their medical records, explore career opportunities, and manage their care conveniently through the Ascension One app and online account. Generated from the website

GlycoMimetics develops novel small molecule therapeutics based upon the roles that carbohydrates play in biological processes. The company believes that carbohydrate mimics, or glycomimetic compounds, represent a new class of drugs. It has identified some compounds with potential therapeutic utility. One class has potential in the treatment of infectious diseases with a novel mechanism of action; the second is a class of anti-inflammatory compounds that have been shown to reduce key measures of inflammation. One of GMI s lead opportunities is to treat or prevent infections caused by Pseudomonas aeruginosa. Its objective in this program is to develop a drug that would be used in conjunction with antibiotics against chronic infections that have failed to respond to antibiotic treatment. The company also has compounds that inhibit selectin binding. Its initial focus in this program is to develop a product to treat acute exacerbations of asthma and chronic obstructive pulmonary disease. GlycoMimetics is headquartered in Gaithersburg, Md.